Education
About Us
Working with TipRanks
Follow Us
Willow Biosciences (TSE:ATLE)
:ATLE
ATLE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.73
Previous CloseN/A
VolumeN/A
Average Volume (3M)105.37K
Market Cap
C$88.06M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.64
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding352,222,660
10 Day Avg. Volume232,293
30 Day Avg. Volume105,368
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
2.07%
Insiders
―
Mutual Funds
0.12% Other Institutional Investors
97.81% Public Companies and
Individual Investors
ATLE FAQ
What was Willow Biosciences’s price range in the past 12 months?
Willow Biosciences lowest stock price was C$0.02 and its highest was C$0.73 in the past 12 months.
What is Willow Biosciences’s market cap?
Willow Biosciences’s market cap is C$88.06M.
When is Willow Biosciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Willow Biosciences’s earnings last quarter?
Currently, no data Available
Is Willow Biosciences overvalued?
According to Wall Street analysts Willow Biosciences’s price is currently Overvalued.
Does Willow Biosciences pay dividends?
Willow Biosciences does not currently pay dividends.
What is Willow Biosciences’s EPS estimate?
Willow Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Willow Biosciences have?
Willow Biosciences has 352,222,660 shares outstanding.
What happened to Willow Biosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Willow Biosciences?
Currently, no hedge funds are holding shares in TSE:ATLE
Willow Biosciences Inc Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.78%
12-Months-Change
Fundamentals
Return on Equity
-971.43%
Trailing 12-Months
Asset Growth
-49.43%
Trailing 12-Months
Company Description
Willow Biosciences
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
Technical Analysis
Terranueva Corp
―
City View Green Holdings
―
Ovation Science
―
New Leaf Ventures
―
Silo Wellness Inc
―